DSpace at RU >

Browsing by Author Pacak, K.

Full Text	Issue Date	Title	Author(s)
	2012	MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma	Burnichon, N.; Cascon, A.; Schiavi, F.; Morales, N.P.; Comino-Mendez, I., et al
	2012	Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.	Eisenhofer, G.; Lenders, J.W.M.; Siegert, G.; Bornstein, S.R.; Friberg, P., et al
	2012	EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma	Taieb, D.; Timmers, H.J.L.M.; Hindie, E.; Guillet, B.A.; Neumann, H.P., et al
	2012	Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.	Timmers, H.J.L.M.; Chen, C.C.; Carrasquillo, J.A.; Whatley, M.; Ling, A., et al
	2012	Subclinical phaeochromocytoma.	Mannelli, M.; Lenders, J.W.M.; Pacak, K.; Parenti, G.; Eisenhofer, G.
	2012	Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma.	Timmers, H.J.L.M.; Taieb, D.; Pacak, K.
	2012	Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution.	Eisenhofer, G.; Vocke, C.D.; Elkahloun, A.; Huynh, T.T.; Prodanov, T., et al
	2011	Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma	Eisenhofer, G.; Lenders, J.W.M.; Timmers, H.; Mannelli, M.; Grebe, S.K., et al
	2011	Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma	Eisenhofer, G.; Pacak, K.; Huynh, T.T.; Qin, N.; Bratslavsky, G., et al
	2011	Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location	Eisenhofer, G.; Timmers, H.J.L.M.; Lenders, J.W.M.; Bornstein, S.R.; Tiebel, O., et al
	2010	Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.	Eisenhofer, G.; Pacak, K.; Huynh, T.T.; Qin, N.; Bratslavsky, G., et al
	2010	Low sensitivity of glucagon provocative testing for diagnosis of pheochromocytoma.	Lenders, J.W.M.; Pacak, K.; Huynh, T.T.; Sharabi, Y.; Mannelli, M., et al
	2009	Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO).	Timmers, H.J.L.M.; Eisenhofer, G.; Carrasquillo, J.A.; Chen, C.C.; Whatley, M., et al
	2009	Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma.	Baid, S.K.; Lai, E.W.; Wesley, R.A.; Ling, A.; Timmers, H.J.L.M., et al
	2009	Penetrance and clinical consequences of a gross SDHB deletion in a large family.	Solis, D.C.; Burnichon, N.; Timmers, H.J.L.M.; Raygada, M.J.; Kozupa, A., et al
	2009	An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.	Nederveen, F.H. van; Gaal, J.; Favier, J.; Korpershoek, E.; Oldenburg, R.A., et al
	2009	Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.	Timmers, H.J.L.M.; Chen, C.C.; Carrasquillo, J.A.; Whatley, M.; Ling, A., et al
	2009	Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.	Timmers, H.J.L.M.; Gimenez-Roqueplo, A.P.; Mannelli, M.; Pacak, K.
	2008	Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.	Zelinka, T.; Timmers, H.J.L.M.; Kozupa, A.; Chen, C.C.; Carrasquillo, J.A., et al
	2008	Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma.	Timmers, H.J.L.M.; Brouwers, F.M.; Hermus, A.R.M.M.; Sweep, F.C.; Verhofstad, A.A.J., et al
	2008	Mutations associated with succinate dehydrogenase D-related malignant paragangliomas.	Timmers, H.J.L.M.; Pacak, K.; Bertherat, J.; Lenders, J.W.M.; Duet, M., et al
	2008	Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma.	Lai, E.W.; Perera, S.M.; Havekes, B.; Timmers, H.J.L.M.; Brouwers, F.M., et al
	2008	Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma	Eisenhofer, G.; Huynh, T.T.; Elkahloun, A.; Morris, J.C.; Bratslavsky, G., et al
	2008	Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.	Timmers, H.J.L.M.; Pacak, K.; Huynh, T.T.; Abu-Asab, M.; Tsokos, M., et al
	2008	Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.	Havekes, B.; Lai, E.W.; Corssmit, E.P.; Romijn, J.A.; Timmers, H.J.L.M., et al
	2007	Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6-18F-fluorodopamine PET.	Timmers, H.J.L.M.; Carrasquillo, J.A.; Whatley, M.; Eisenhofer, G.; Chen, C.C., et al
	2007	The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.	Timmers, H.J.L.M.; Hadi, M.; Carrasquillo, J.A.; Chen, C.C.; Martiniova, L., et al
	2007	Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.	Timmers, H.J.L.M.; Kozupa, A.; Eisenhofer, G.; Raygada, M.; Adams, K.T., et al
	2007	Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.	Timmers, H.J.L.M.; Kozupa, A.; Chen, C.C.; Carrasquillo, J.A.; Ling, A., et al
	2007	Is supine rest necessary before blood sampling for plasma metanephrines?	Lenders, J.W.M.; Willemsen, J.J.; Eisenhofer, G.; Ross, H.A.; Pacak, K., et al
	2006	Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus?	Grossman, A.; Pacak, K.; Sawka, A.; Lenders, J.W.M.; Harlander, D., et al
	2006	Gene expression profiling of benign and malignant pheochromocytoma.	Brouwers, F.M.; Elkahloun, A.G.; Munson, P.J.; Eisenhofer, G.; Barb, J., et al
	2005	Phaeochromocytoma.	Lenders, J.W.M.; Eisenhofer, G.; Mannelli, M.; Pacak, K.
	2005	Plasma metanephrines in renal failure.	Eisenhofer, G.; Huysmans, F.T.M.; Pacak, K.; Walther, M.M.; Sweep, C.G.J., et al
	2005	Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.	Eisenhofer, G.; Lenders, J.W.M.; Goldstein, D.S.; Mannelli, M.; Csako, G., et al
	2004	Biochemical diagnosis of pheochromocytoma	Eisenhofer, G.; Lenders, J.W.M.; Pacak, K.
	1995	Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism?	Eisenhofer, G.; Friberg, P.; Pacak, K.; Goldstein, D.S.; Murphy, D.L., et al